Clone Phylogenetics Reveals Metastatic Tumor Migrations, Maps, and Models

被引:5
|
作者
Chroni, Antonia [1 ,2 ]
Miura, Sayaka [1 ,2 ]
Hamilton, Lauren [1 ,2 ]
Vu, Tracy [1 ,2 ]
Gaffney, Stephen G. [3 ]
Aly, Vivian [1 ,2 ]
Karim, Sajjad [4 ]
Sanderford, Maxwell [1 ,2 ]
Townsend, Jeffrey P. [3 ,5 ,6 ]
Kumar, Sudhir [1 ,2 ,4 ]
机构
[1] Temple Univ, Inst Genom & Evolutionary Med, Philadelphia, PA 19122 USA
[2] Temple Univ, Dept Biol, Philadelphia, PA 19122 USA
[3] Yale Univ, Dept Biostat, New Haven, CT 06510 USA
[4] King Abdulaziz Univ, Ctr Excellence Genom Med Res, Jeddah 22252, Saudi Arabia
[5] Yale Univ, Dept Ecol & Evolutionary Biol, New Haven, CT 06525 USA
[6] Yale Univ, Program Computat Biol & Bioinformat, New Haven, CT 06511 USA
基金
美国国家卫生研究院;
关键词
tumor evolution; metastasis; molecular evolution; phylogenetics; phylodynamics; cancer; HETEROGENEITY;
D O I
10.3390/cancers14174326
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Simple Summary Metastasis is the spread of cancer cells across organs and is a major cause of cancer mortality. Analysis of tumor sequencing data provides a means toward the reconstruction of routes of metastatic cell migrations. Our reconstructions demonstrated that many metastases were likely seeded from pre-existing metastasis of primary tumors. Additionally, multiple clone exchanges between tumor sites were common. In conclusion, the pattern of cancer cell migrations is often complex and is highly variable among patients. Dispersal routes of metastatic cells are not medically detected or even visible. A molecular evolutionary analysis of tumor variation provides a way to retrospectively infer metastatic migration histories and answer questions such as whether the majority of metastases are seeded from clones within primary tumors or seeded from clones within pre-existing metastases, as well as whether the evolution of metastases is generally consistent with any proposed models. We seek answers to these fundamental questions through a systematic patient-centric retrospective analysis that maps the dynamic evolutionary history of tumor cell migrations in many cancers. We analyzed tumor genetic heterogeneity in 51 cancer patients and found that most metastatic migration histories were best described by a hybrid of models of metastatic tumor evolution. Synthesizing across metastatic migration histories, we found new tumor seedings arising from clones of pre-existing metastases as often as they arose from clones from primary tumors. There were also many clone exchanges between the source and recipient tumors. Therefore, a molecular phylogenetic analysis of tumor variation provides a retrospective glimpse into general patterns of metastatic migration histories in cancer patients.
引用
收藏
页数:13
相关论文
共 48 条
  • [1] Inferring models of multiscale copy number evolution for single-tumor phylogenetics
    Chowdhury, Salim Akhter
    Gertz, E. Michael
    Wangsa, Darawalee
    Heselmeyer-Haddad, Kerstin
    Ried, Thomas
    Schaeffer, Alejandro A.
    Schwartz, Russell
    BIOINFORMATICS, 2015, 31 (12) : 258 - 267
  • [2] Mechanisms of vascularization in murine models of primary and metastatic tumor growth
    Bugyik, Edina
    Renyi-Vamos, Ferenc
    Szabo, Vanessza
    Dezso, Katalin
    Ecker, Nora
    Rokusz, Andras
    Nagy, Peter
    Dome, Balazs
    Paku, Sandor
    CHINESE JOURNAL OF CANCER, 2016, 35
  • [3] Biofabrication approaches and regulatory framework of metastatic tumor-on-a-chip models for precision oncology
    Nieto, Daniel
    Jimenez, Gema
    Moroni, Lorenzo
    Lopez-Ruiz, Elena
    Galvez-Martin, Patricia
    Marchal, Juan Antonio
    MEDICINAL RESEARCH REVIEWS, 2022, 42 (05) : 1978 - 2001
  • [4] Temporal Genomic Analysis of Homogeneous Tumor Models Reveals Key Regulators of Immune Evasion in Melanoma
    Cohen Shvefel, Sapir
    Pai, Joy A.
    Cao, Yingying
    Pal, Lipika R.
    Bartok, Osnat
    Levy, Ronen
    Zemanek, Marie J.
    Weller, Chen
    Herzog, Ella
    Yao, Winnie
    Hiam-Galvez, Kamir J.
    Cheng, Kuoyuan
    Yin, Yajie
    Du, Peter P.
    Raposo, Colin J.
    Gumpert, Nofar
    Welti, Michele
    Martinez Gomez, Julia M.
    Sella, Federica
    Yakubovich, Elizabeta
    Orr, Irit
    Ben-Dor, Shifra
    Oren, Roni
    Fellus-Alyagor, Liat
    Golani, Ofra
    Brenner, Ori Jacob
    Salame, Tomer M.
    Zerbib, Mirie
    Goliand, Inna
    Ranmar, Dean
    Savchenko, Ilya
    Ketrarou, Nadav
    Schaeffer, Alejandro A.
    Dahan, Rony
    Levesque, Mitchell P.
    Ruppin, Eytan
    Satpathy, Ansuman T.
    Samuels, Yardena
    CANCER DISCOVERY, 2025, 15 (03) : 553 - 577
  • [5] Mechanisms of vascularization in murine models of primary and metastatic tumor growth
    Edina Bugyik
    Ferenc RenyiVamos
    Vanessza Szabo
    Katalin Dezso
    Nora Ecker
    Andras Rokusz
    Peter Nagy
    Balazs Dome
    Sandor Paku
    ChineseJournalofCancer, 2016, 35 (02) : 58 - 65
  • [6] Multiomics profiling of primary lung cancers and distant metastases reveals immunosuppression as a common characteristic of tumor cells with metastatic plasticity
    Lee, Won-Chul
    Reuben, Alexandre
    Hu, Xin
    McGranahan, Nicholas
    Chen, Runzhe
    Jalali, Ali
    Negrao, Marcelo, V
    Hubert, Shawna M.
    Tang, Chad
    Wu, Chia-Chin
    San Lucas, Anthony
    Roh, Whijae
    Suda, Kenichi
    Kim, Jihye
    Tan, Aik-Choon
    Peng, David H.
    Lu, Wei
    Tang, Ximing
    Chow, Chi-Wan
    Fujimoto, Junya
    Behrens, Carmen
    Kalhor, Neda
    Fukumura, Kazutaka
    Coyle, Marcus
    Thornton, Rebecca
    Gumbs, Curtis
    Li, Jun
    Wu, Chang-Jiun
    Little, Latasha
    Roarty, Emily
    Song, Xingzhi
    Lee, J. Jack
    Sulman, Erik P.
    Rao, Ganesh
    Swisher, Stephen
    Diao, Lixia
    Wang, Jing
    Heymach, John, V
    Huse, Jason T.
    Scheet, Paul
    Wistuba, Ignacio I.
    Gibbons, Don L.
    Futreal, P. Andrew
    Zhang, Jianhua
    Gomez, Daniel
    Zhang, Jianjun
    GENOME BIOLOGY, 2020, 21 (01)
  • [7] In vitro and in vivo investigation of matrix metalloproteinase expression in metastatic tumor models
    Sprague, JE
    Li, WP
    Liang, KX
    Achilefu, S
    Anderson, CJ
    NUCLEAR MEDICINE AND BIOLOGY, 2006, 33 (02) : 227 - 237
  • [8] DNA barcoded competitive clone-initiating cell analysis reveals novel features of metastatic growth in a cancer xenograft model
    Aalam, Syed Mohammed Musheer
    Tang, Xiaojia
    Song, Jianning
    Ray, Upasana
    Russell, Stephen J.
    Weroha, S. John
    Bakkum-Gamez, Jamie
    Shridhar, Viji
    Sherman, Mark E.
    Eaves, Connie J.
    Knapp, David J. H. F.
    Kalari, Krishna R.
    Kannan, Nagarajan
    NAR CANCER, 2022, 4 (03):
  • [9] Single-Cell RNA-Sequencing Atlas Reveals the Tumor Microenvironment of Metastatic High-Grade Serous Ovarian Carcinoma
    Deng, Yingqing
    Tan, Yuan
    Zhou, Dongmei
    Bai, Youhuang
    Cao, Ting
    Zhong, Caizhou
    Huang, Weilai
    Ou, Yuhua
    Guo, Linlang
    Liu, Qianqian
    Yin, Deling
    Chen, Lipai
    Luo, Xiping
    Sun, Deqiang
    Sheng, Xiujie
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [10] Targeted transcriptional profiling of the tumor microenvironment reveals lymphocyte exclusion and vascular dysfunction in metastatic osteosarcoma
    Sorenson, Laurie
    Fu, Yanfen
    Hood, Tressa
    Warren, Sarah
    McEachron, Troy A.
    ONCOIMMUNOLOGY, 2019, 8 (09):